GMC is proud to support the QUEST Initiative at the University of Sydney
Recruiting patients for medicinal cannabis QoL study!
The QUEST Initiative Quality-of-life, Evaluation Study, conducted by researchers at the University of Sydney, is aiming to be the world’s largest QoL study, assessing medicinal cannabis and the economic impact of this treatment option on patients, through the recruitment of 5,000 patients.
Recruitment criteria is patients must be cannabis naïve or not have used a medicinal cannabis product for 30 days, and able to take medication for a minimum of three months.
This study is available for patients with any condition for which medical cannabis may be suitable.
The cost of the medication is $150 plus $15 delivery.
Talk to to our doctor today about the Quest initiative.